68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics
dc.contributor.author | Mittal, S. | |
dc.contributor.author | Sharma, R. | |
dc.contributor.author | Mallia, M. B. | |
dc.contributor.author | Sarma, H. D. | |
dc.date.accessioned | 2022-08-02T09:42:41Z | |
dc.date.available | 2022-08-02T09:42:41Z | |
dc.date.issued | 2021 | |
dc.description.division | RPhD;RB&HSD | en |
dc.format.extent | 5628 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Nuclear Medicine and Biology, 2021. Vol. 96-97: pp. 61-67 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/24885 | |
dc.language.iso | en | en |
dc.subject | Tumor hypoxia | en |
dc.subject | Nitroimidazole | en |
dc.subject | Gallium-68 | en |
dc.subject | Positron emission tomography | en |
dc.subject | Bifunctional chelating agent | en |
dc.subject | BFCA | en |
dc.title | 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics | en |
dc.type | Article | en |